Palvella Therapeutics, Inc. Common Stock (PVLA) News
Latest headlines that mention PVLA, newest first · each headline opens the original publisher
- Last price
- $174.93
- Day change
- -0.57%
- Next earnings
- —
PVLA headlines
last 30 daysQTORIN rapamycin wins priority FDA review for a rare vascular disease.
PVLA news alerts
Get an alert by email or push when a new headline mentions PVLA.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.